UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector

Nature medicine, 1999-01, Vol.5 (1), p.56-63

1999

Volltextzugriff (PDF)

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors

Nature medicine, 1999-01, Vol.5 (1), p.64-70

1999

Volltextzugriff (PDF)

Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia B

Thrombosis and haemostasis, 1997, Vol.77 (5), p.944-948

1997

Volltextzugriff (PDF)

Role of Botrocetin in Platelet Agglutination: Formation of an Activated Complex of Botrocetin and von Willebrand Factor

Blood, 1989-08, Vol.74 (3), p.1031-1035

1989

Volltextzugriff (PDF)

Pharmacokinetics of recombinant factor IX after intravenous and subcutaneous administration in dogs and cynomolgus monkeys

Thrombosis and haemostasis, 2002-05, Vol.87 (5), p.824-830

2002

Volltextzugriff (PDF)

Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs

Gene therapy, 1996-03, Vol.3 (3), p.217

1996

Volltextzugriff (PDF)

Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression

Human gene therapy, 1995-08, Vol.6 (8), p.1039-1044

1995

Volltextzugriff (PDF)

Recombinant human factor IX : Replacement therapy, Prophylaxis, and pharmacokinetics in canine hemophilia B

Blood, 1996-10, Vol.88 (7), p.2603-2610

1996

Volltextzugriff (PDF)

Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B

The Journal of clinical investigation, 1997-08, Vol.100 (4), p.886-892

1997

Volltextzugriff (PDF)

Thrombotic thrombocytopenia induced in dogs and pigs. The role of plasma and platelet vWF in animal models of thrombotic thrombocytopenic purpura

Arteriosclerosis, thrombosis, and vascular biology, 1995-06, Vol.15 (6), p.793-800

1995

Volltextzugriff (PDF)

The Roles of von Willebrand Factor and Factor VIII in Arterial Thrombosis: Studies in Canine von Willebrand Disease and Hemophilia A

Blood, 1993-05, Vol.81 (10), p.2644-2651

1993

Volltextzugriff (PDF)

Gene transfer in the hemophilias: Retrospect and prospect

Thrombosis research, 1992-08, Vol.67 (3), p.329-338

Brinkhous, Kenneth M.

1992

Volltextzugriff (PDF)

Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexes

Human gene therapy, 1994-03, Vol.5 (3), p.313-322

1994

Volltextzugriff (PDF)

Use of Venom Coagglutinin and Lyophilized Platelets in Testing for Platelet-Aggregating von Willebrand Factor

Blood, 1980-03, Vol.55 (3), p.517-520

1980

Volltextzugriff (PDF)

Advances and controversies in blood coagulation: a 50‐year retrospective

The FASEB journal, 1992-02, Vol.6 (3), p.925-926

Brinkhous, Kenneth M.

1992

Volltextzugriff (PDF)

The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A

Blood, 1993-05, Vol.81 (10), p.2644-2651

1993

Volltextzugriff (PDF)

Treatment for Hemophilia: Gene Therapy vs Transplantation-Reply

JAMA : the journal of the American Medical Association, 1994-05, Vol.271 (20), p.1576

Lozier, Jay Nelson

1994

Volltextzugriff (PDF)

Porcine von Willebrand disease and atherosclerosis. Influence of polymorphism in apolipoprotein B100 genotype

The American journal of pathology, 1992-02, Vol.140 (2), p.403-415

1992

Volltextzugriff (PDF)

Inventory of Exogenous Platelet-Aggregating Agents Derived from Venoms

Thrombosis and haemostasis, 1991, Vol.66 (2), p.259-263

1991

Volltextzugriff (PDF)

[12] Fixation platelets and platelet agglutination/aggregation tests

Methods in Enzymology, 1989, Vol.169, p.149-163

1989

Volltextzugriff (PDF)

Comparison of Inhibitory and Binding Characteristics of an Antibody Causing Acquired von Willebrand Syndrome: An Assay for von Willebrand Factor Binding by Antibody

Blood, 1985-09, Vol.66 (3), p.562-569

1985

Volltextzugriff (PDF)

Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia B

Haemophilia : the official journal of the World Federation of Hemophilia, 1997-07, Vol.3 (3), p.231-231

1997

Volltextzugriff (PDF)

Glycoprotein Ib bioassays. Activity levels in Bernard-Soulier syndrome and in stored blood bank platelets

Archives of pathology & laboratory medicine (1976), 1991-05, Vol.115 (5), p.488

1991

Volltextzugriff (PDF)

NOMENCLATURE OF EXOGENOUS HEMOSTATIC FACTORS

Blood, 1993-01, Vol.81 (1), p.272-272

1993

Volltextzugriff (PDF)

Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand factor

Blood, 1989-08, Vol.74 (3), p.1031-1035

1989

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(105)

Sprache

Englisch
(105)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors

Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia B

Role of Botrocetin in Platelet Agglutination: Formation of an Activated Complex of Botrocetin and von Willebrand Factor

Pharmacokinetics of recombinant factor IX after intravenous and subcutaneous administration in dogs and cynomolgus monkeys

Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs

Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression

Recombinant human factor IX : Replacement therapy, Prophylaxis, and pharmacokinetics in canine hemophilia B

Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B

Thrombotic thrombocytopenia induced in dogs and pigs. The role of plasma and platelet vWF in animal models of thrombotic thrombocytopenic purpura

The Roles of von Willebrand Factor and Factor VIII in Arterial Thrombosis: Studies in Canine von Willebrand Disease and Hemophilia A

Gene transfer in the hemophilias: Retrospect and prospect

Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexes

Use of Venom Coagglutinin and Lyophilized Platelets in Testing for Platelet-Aggregating von Willebrand Factor

Advances and controversies in blood coagulation: a 50‐year retrospective

The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A

Treatment for Hemophilia: Gene Therapy vs Transplantation-Reply

Porcine von Willebrand disease and atherosclerosis. Influence of polymorphism in apolipoprotein B100 genotype

Inventory of Exogenous Platelet-Aggregating Agents Derived from Venoms

[12] Fixation platelets and platelet agglutination/aggregation tests

Comparison of Inhibitory and Binding Characteristics of an Antibody Causing Acquired von Willebrand Syndrome: An Assay for von Willebrand Factor Binding by Antibody

Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia B

Glycoprotein Ib bioassays. Activity levels in Bernard-Soulier syndrome and in stored blood bank platelets

NOMENCLATURE OF EXOGENOUS HEMOSTATIC FACTORS

Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand factor

Aktive Filter

Suchergebnisse filtern